SILVERARC CAPITAL MANAGEMENT, LLC

Adviser information for SILVERARC CAPITAL MANAGEMENT, LLC last updated from Form ADV on March 25th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 7
Investment Advisory/Research 5
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 5 $538.7M
Non-Discretionary 0 $0
Total 5 $538.7M

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 3 $354.6M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 2 $184.1M
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 30

Services

Advisory Services Portfolio management for pooled investment vehiclesPortfolio management for businesses or institutional clients
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-116845
SEC ERA File Number 801-116845
SEC CIK Numbers 1816307
SEC CRD Numbers 304220
Legal Entity Identifier None

Principal Office

20 PARK PLAZA
SUITE 1116
BOSTON
MA
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 617-284-6952, Fax: None

Chief Compliance Officer

ANDREW TIMPSON
CHIEF OPERATING OFFICER
20 PARK PLAZA
4TH FLOOR
BOSTON
MA
United States
Tel: 617-284-6952
(Full email address available in API data)

Industry Affiliates

SILVERARC CAPITAL, LLC Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
SILVERARC CAPITAL ALPHA FUND I, L.P. Hedge Fund $24.5M $0.3M 24
SILVERARC CAPITAL ALPHA FUND II, L.P. Hedge Fund $456.6M $1.0M 81

Control Persons

Name Type Entity Title Since Ownership
GANDHI, DEVESH, SHARAD Individual FOUNDER & PRESIDENT 04/2019 > 75%
TIMPSON, ANDREW, JOSEPH Individual CHIEF OPERATING OFFICER & CHIEF COMPLIANCE OFFICER 07/2019 < 5%

No. Employees, Historic

105020192020202120222023202420252 on 5/24/20193 on 10/16/20193 on 3/13/20204 on 3/12/20214 on 8/5/20215 on 3/28/20226 on 3/24/20237 on 3/25/2024

RAUM, Historic

600M300M020192020202120222023202420250 on 5/24/2019145851776 on 10/16/2019176471919 on 3/13/2020317784322 on 3/12/2021317784322 on 8/5/2021320271919 on 3/28/2022441597686 on 3/24/2023538709225 on 3/25/2024

No. Clients, Historic

105020192020202120222023202420250 on 5/24/20194 on 10/16/20194 on 3/13/20204 on 3/12/20214 on 8/5/20215 on 3/28/20225 on 3/24/20235 on 3/25/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
89BIO INC COM 739K 92K
ABIVAX SA SPONSORED ADS 6M 456K
ADC THERAPEUTICS SA SHS 6M 2M
AKERO THERAPEUTICS INC COM 15M 625K
ALIGOS THERAPEUTICS INC COM 229K 656K
ALNYLAM PHARMACEUTICALS INC COM 9M 36K
ALX ONCOLOGY HLDGS INC PUT 1M 168K
AVIDITY BIOSCIENCES INC COM 21M 518K
BIODESIX INC COM 3M 2M
BIOGEN INC COM 4M 19K
BIOHAVEN LTD COM 3M 100K
C4 THERAPEUTICS INC COM STK 7M 1M
C4 THERAPEUTICS INC CALL 693K 150K
CELLDEX THERAPEUTICS INC NEW COM NEW 14M 375K
CERUS CORP COM 3M 1M
COGENT BIOSCIENCES INC COM 10M 1M
COMPUGEN LTD ORD 3M 2M
CORBUS PHARMACEUTICALS HLDGS COM NEW 8M 172K
DISC MEDICINE INC COM 5M 101K
ELUTIA INC CL A COM 8M 2M
ENGENE HOLDINGS INC COM 2M 264K
ERASCA INC COM 18M 8M
EVOGENE LTD SHS 2M 3M
EYEPOINT PHARMACEUTICALS INC COM NEW 870K 100K
FRACTYL HEALTH INC COM 712K 167K
FULCRUM THERAPEUTICS INC COM 2M 398K
GERON CORP COM 4M 999K
GOSSAMER BIO INC COM 5M 6M
HELIX ACQUISITION CORP II CL A ORD SHS 5M 500K
INSMED INC COM PAR $.01 9M 140K
INSMED INC CALL 17M 250K
INTRA-CELLULAR THERAPIES INC COM 13M 192K
JASPER THERAPEUTICS INC COM NEW 2M 110K
KALVISTA PHARMACEUTICALS INC COM 7M 561K
KARYOPHARM THERAPEUTICS INC COM 485K 558K
KODIAK SCIENCES INC COM 2M 1M
LONGBOARD PHARMACEUTICALS IN COM 3M 123K
MACROGENICS INC COM 2M 370K
MERSANA THERAPEUTICS INC COM 5M 3M
MERSANA THERAPEUTICS INC CALL 338K 168K
MERUS N V COM 37M 624K
MIRUM PHARMACEUTICALS INC COM 3M 79K
MODULAR MED INC COM NEW 1M 900K
MOLECULAR TEMPLATES INC COM NEW 717K 624K
MORPHIC HLDG INC COM 17M 486K
NUVALENT INC COM 35M 466K
OLEMA PHARMACEUTICALS INC COM 6M 547K
ORIC PHARMACEUTICALS INC COM 8M 1M
PERSPECTIVE THERAPEUTICS INC COM NEW 3M 260K
POSEIDA THERAPEUTICS INC COM 11M 4M
PRAXIS PRECISION MEDICINES I COM NEW 3M 67K
RELMADA THERAPEUTICS INC COM 298K 99K
RHYTHM PHARMACEUTICALS INC COM 8M 185K
ROCKET PHARMACEUTICALS INC *W EXP 09/02/202 6K 105K
SAREPTA THERAPEUTICS INC COM 7M 42K
SOLENO THERAPEUTICS INC COM 612K 15K
SOLID BIOSCIENCES INC COM NEW 3M 473K
STOKE THERAPEUTICS INC COM 2M 142K
STRUCTURE THERAPEUTICS INC SPONSORED ADS 3M 71K
SYNDAX PHARMACEUTICALS INC COM 8M 370K
TARSUS PHARMACEUTICALS INC COM 1M 40K
TELA BIO INC COM 5M 1M
TREVI THERAPEUTICS INC COM 3M 844K
UROGEN PHARMA LTD COM 18M 1M
VAXCYTE INC COM 189K 3K
VERACYTE INC COM 6M 282K
VERONA PHARMA PLC SPONSORED ADS 4M 305K
VYNE THERAPEUTICS INC COM 921K 467K
WAVE LIFE SCIENCES LTD SHS 2M 495K
ZURA BIO LTD CLASS A ORD SHS 1M 329K